Back to Search
Start Over
Differential Selection of Single-Step AmpC or Efflux Mutants of Pseudomonas aeruginosa by Using Cefepime, Ceftazidime, or Ceftobiprole
- Source :
- Antimicrobial Agents and Chemotherapy. 54:4092-4097
- Publication Year :
- 2010
- Publisher :
- American Society for Microbiology, 2010.
-
Abstract
- Single-step Pseudomonas aeruginosa mutants, selected with ceftobiprole, ceftazidime, or cefepime, were generated at frequencies of 10 −6 to −9 at two and four times the MIC. The chromosomal AmpC β-lactamase activity was increased in all ceftazidime-selected mutants. Mutants selected with cefepime either increased AmpC activity or upregulated expression of the mexXY efflux genes. Mutants selected with ceftobiprole did not overexpress AmpC; 90% of these produced elevated levels of mexXY RNA, indicating that increased efflux, not AmpC derepression, is the predominant response to ceftobiprole during first-step mutations in P. aeruginosa .
- Subjects :
- medicine.medical_treatment
Cefepime
Ceftobiprole
Ceftazidime
Microbial Sensitivity Tests
medicine.disease_cause
beta-Lactamases
Microbiology
Bacterial Proteins
Mechanisms of Resistance
medicine
Pharmacology (medical)
Derepression
Antibacterial agent
Pharmacology
Pseudomonas aeruginosa
Chemistry
biochemical phenomena, metabolism, and nutrition
Anti-Bacterial Agents
Cephalosporins
Infectious Diseases
Mutation
Beta-lactamase
Efflux
medicine.drug
Subjects
Details
- ISSN :
- 10986596 and 00664804
- Volume :
- 54
- Database :
- OpenAIRE
- Journal :
- Antimicrobial Agents and Chemotherapy
- Accession number :
- edsair.doi.dedup.....922f9ccbf51e04f298d68eea138b39ce
- Full Text :
- https://doi.org/10.1128/aac.00060-10